P083 Importance of preventing “healthy” part of lung microbiome
Olga L. Voronina, Gintsburg Al(Gamalei Institute of Epidemiology and Microbiology), Л. Н. Капотина, Ekaterina I. Aksenova, А. Г. Чучалин(City Clinical Hospital), О. И. Симонова, Marina S. Kunda, A. Lasareva, Н. Н. Рыжова, G. А. Danilina, Vera P. Chernevich, Stanislava Andreevna Saidakova, Elena A. Amelina, Н. А. Зигангирова, E. Kondratyeva(Cystic Fibrosis Research Foundation)
Cited by 0
Related Papers
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
|The Lancet|2021|1.8k
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
|Clinical & Experimental Allergy|2004|520
Rehabilitation in the intensive care unit (RehabICU). Clinical practice recommendations of the national Union of Physical and Rehabilitation Medicine Specialists of Russia and of the national Federation of Anesthesiologists and Reanimatologists
|Annals of critical care|2022|54
Sporadic ALS associated with the D90A Cu,Zn superoxide dismutase mutation in Russia
|European Journal of Neurology|2001|29
Vegetative State: Difficulty in Identifying Consciousness and Predicting Outcome
|Annals of the Russian academy of medical sciences|2016|13